Pediatric genitourinary tumors

Current Opinion in Oncology

Volumn 12, Issue 3, 2000, Pages 273-281

  Herz, Daniel ^a   McLellan, Dawn ^a   Garrels, Kristina ^a   Merguerian, Paul A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Valley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; GENE MAPPING; GENETIC HETEROGENEITY; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; NEPHROBLASTOMA; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SOMATIC MUTATION; TESTIS TUMOR; UROGENITAL TRACT CANCER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; RHABDOMYOSARCOMA; TESTICULAR NEOPLASMS; UROGENITAL NEOPLASMS; WILMS TUMOR;

EID: 0034524130     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200005000-00015     Document Type: Review

References (48)

1. Bilateral Wilms tumor
2. Wilms tumor genetics
3. Genetics of Wilms tumor
4. Constitutional WT1 mutations in Wilms tumor patients
5. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
6. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction
7. Mosaic allelic IGF-2 expression patterns reveal a link between Wilms tumorigenesis and epigenic heterogeneity
8. Loss of heterozygosity on chromosome 16 in sporadic Wilms Tumor
9. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms Tumor
10. Wilms tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun
11. Proto-oncogene N-myc promotor is down regulated by WT1 suppressor gene
12. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilm tumor
13. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms tumor
14. Metastasis correlates with production of VEGF in a murine model of human Wilms tumor
15. Wilms tumor and related abnormalities in the fetus and newborn
16. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy
17. Factors affecting the risk of contralateral Wilms tumor development: A report from the NWTS Group
18. With advances in medical imaging can the radiologist reliably diagnose Wilms tumor
19. Pretreatment, ultrasound-guided cutting needle biopsies in childhood renal tumors
20. New definitions of local and diffuse anaplasia Wilms tumor: The International Society of Pediatric Oncology (SIOP) experience
21. Significance and management of computed tomography detected pulmonary nodules: A report from the NWTS group
22. Hepatoloxicity in patients treated according to the Nephroblastoma Trial and Study SIOP-9/GPOH
23. Wilms tumor: A 25-year review of the role of preoperative chemotherapy
24. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms tumor: A report from the NWTS group
25. Surgery-related factors and local recurrence of Wilms tumor in NWTS-4
26. Multiple roles for the Wilms tumor suppressor, WT1
27. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms tumor alters gene function
28. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
29. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
30. Renal findings on radiological follow-up of patients with Beckwith-Wiedemann syndrome
31. Microdissecting the genetic events in nephrogenic rests and Wilms tumor development
32. Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations
33. Cadherin-11 highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro
34. Studies on the mechanism of resistance to rapamycin in human cancer cells
35. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
36. Expression of CD44 by rhabdomyosarcoma: A new prognostic marker?
37. Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells
38. Functional characterization of the human PAX3 gene regulatory region
39. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?
40. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: Its correlation with histologic features
41. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells
42. GR-891: A novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells
43. Testicular and paratesticular tumours in children: 30 Years' experience
44. Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex, age-, site-, and histopathology-related difference: A Children's Cancer Group study
45. Genomic imprinting of H19 and insulin like growth factor-2 in pediatric germ cell tumors
46. Primary follicular lymphoma of the testis in childhood
47. Tumors of the adrenogenital syndrome: An aggressive conservative approach
48. Prepubertal testicular teratomas